{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T13:28:57Z","timestamp":1769347737745,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"University of Cincinnati College of Medicine Special Coronavirus (COVID-19) Research Pilot Grant Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s11239-021-02597-y","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T14:02:42Z","timestamp":1635429762000},"page":"581-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The role of lipoprotein(a) in coronavirus disease 2019 (COVID-19) with relation to development of severe acute kidney injury"],"prefix":"10.1007","volume":"53","author":[{"given":"Giuseppe","family":"Lippi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Szergyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Helena Santos","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie W.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin L.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon Michael","family":"Henry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"2597_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cca.2020.04.027","volume":"507","author":"BM Henry","year":"2020","unstructured":"Henry BM, Vikse J, Benoit S, Favaloro EJ, Lippi G (2020) Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta Int J Clin Chem 507:167\u2013173","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"1","key":"2597_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11239-020-02134-3","volume":"50","author":"RC Becker","year":"2020","unstructured":"Becker RC (2020) COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis 50(1):54\u201367","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"2597_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.mayocp.2020.10.031","volume":"96","author":"G Lippi","year":"2021","unstructured":"Lippi G, Sanchis-Gomar F, Favaloro EJ, Lavie CJ, Henry BM (2021) Coronavirus disease 2019\u2013associated coagulopathy. Mayo Clin Proc 96(1):203\u2013217","journal-title":"Mayo Clin Proc"},{"key":"2597_CR4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","volume":"191","author":"FA Klok","year":"2020","unstructured":"Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM et al (2020) Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res 191:145\u2013147","journal-title":"Thromb Res"},{"issue":"8","key":"2597_CR5","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1111\/jth.14888","volume":"18","author":"S Middeldorp","year":"2020","unstructured":"Middeldorp S, Coppens M, van Haaps TF, Foppen M, Vlaar AP, M\u00fcller MCA et al (2020) Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost JTH 18(8):1995\u20132002","journal-title":"J Thromb Haemost JTH"},{"key":"2597_CR6","doi-asserted-by":"publisher","first-page":"3746","DOI":"10.3390\/jcm9113746","volume":"9","author":"O Grzegorowska","year":"2020","unstructured":"Grzegorowska O, Lorkowski J (2020) Possible correlations between atherosclerosis, acute coronary syndromes and COVID-19. J Clin Med 9:3746","journal-title":"J Clin Med"},{"key":"2597_CR7","doi-asserted-by":"publisher","first-page":"154243","DOI":"10.1016\/j.metabol.2020.154243","volume":"107","author":"J Fan","year":"2020","unstructured":"Fan J, Wang H, Ye G, Cao X, Xu X, Tan W et al (2020) Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019. Metabolism 107:154243","journal-title":"Metabolism"},{"issue":"1","key":"2597_CR8","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12944-020-01382-9","volume":"19","author":"G Wang","year":"2020","unstructured":"Wang G, Zhang Q, Zhao X, Dong H, Wu C, Wu F et al (2020) Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study. Lipids Health Dis 19(1):204","journal-title":"Lipids Health Dis"},{"issue":"3","key":"2597_CR9","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.jacl.2020.04.008","volume":"14","author":"X Wei","year":"2020","unstructured":"Wei X, Zeng W, Su J, Wan H, Yu X, Cao X et al (2020) Hypolipidemia is associated with the severity of COVID-19. J Clin Lipidol 14(3):297\u2013304","journal-title":"J Clin Lipidol"},{"issue":"1","key":"2597_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/713609328","volume":"40","author":"G Lippi","year":"2003","unstructured":"Lippi G, Guidi G (2003) Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci 40(1):1\u201342","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"2597_CR11","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1194\/jlr.P052209","volume":"56","author":"N M\u00fcller","year":"2015","unstructured":"M\u00fcller N, Schulte DM, T\u00fcrk K, Freitag-Wolf S, Hampe J, Zeuner R et al (2015) IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans. J Lipid Res 56(5):1034\u20131042","journal-title":"J Lipid Res"},{"issue":"1","key":"2597_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1056\/NEJMoa043175","volume":"353","author":"S Tsimikas","year":"2005","unstructured":"Tsimikas S, Brilakis ES, Miller ER, McConnell JP, Lennon RJ, Kornman KS et al (2005) Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 353(1):46\u201357","journal-title":"N Engl J Med"},{"key":"2597_CR13","doi-asserted-by":"publisher","first-page":"4807084","DOI":"10.1155\/2012\/480784","volume":"2012","author":"I Missala","year":"2012","unstructured":"Missala I, Kassner U, Steinhagen-Thiessen E (2012) A systematic literature review of the association of Lipoprotein(a) and autoimmune diseases and atherosclerosis. Int J Rheumatol 2012:4807084","journal-title":"Int J Rheumatol"},{"issue":"9","key":"2597_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11883-020-00867-3","volume":"22","author":"PM Moriarty","year":"2020","unstructured":"Moriarty PM, Gorby LK, Stroes ES, Kastelein JP, Davidson M, Tsimikas S (2020) Lipoprotein(a) and its potential association with thrombosis and inflammation in COVID-19: a testable hypothesis. Curr Atheroscler Rep 22(9):48","journal-title":"Curr Atheroscler Rep"},{"issue":"10","key":"2597_CR15","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","volume":"98","author":"NM Caplice","year":"2001","unstructured":"Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM et al (2001) Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood 98(10):2980\u20132987","journal-title":"Blood"},{"issue":"10","key":"2597_CR16","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1182\/blood.V96.10.3364","volume":"96","author":"M von Depka","year":"2000","unstructured":"von Depka M, Nowak-G\u00f6ttl U, Eisert R, Dieterich C, Barthels M, Scharrer I et al (2000) Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism. Blood 96(10):3364\u20133368","journal-title":"Blood"},{"issue":"2","key":"2597_CR17","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2015.08.021","volume":"242","author":"AH Nave","year":"2015","unstructured":"Nave AH, Lange KS, Leonards CO, Siegerink B, Doehner W, Landmesser U et al (2015) Lipoprotein (a) as a risk factor for ischemic stroke: a meta-analysis. Atherosclerosis 242(2):496\u2013503","journal-title":"Atherosclerosis"},{"issue":"4","key":"2597_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00296-004-0438-0","volume":"25","author":"D Dursuno\u011flu","year":"2005","unstructured":"Dursuno\u011flu D, Evreng\u00fcl H, Polat B, Tanr\u0131verdi H, \u00c7obankara V, Kaftan A et al (2005) Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int 25(4):241\u2013245","journal-title":"Rheumatol Int"},{"issue":"4","key":"2597_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1055\/s-0038-1649872","volume":"74","author":"K Kario","year":"1995","unstructured":"Kario K, Matsuo T, Kobayashi H, Matsuo M, Asada R, Koide M (1995) High lipoprotein (a) levels in chronic hemodialysis patients are closely related to the acute phase reaction. Thromb Haemost 74(4):1020\u20131024","journal-title":"Thromb Haemost"},{"issue":"1","key":"2597_CR20","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2014.01.049","volume":"234","author":"A Langsted","year":"2014","unstructured":"Langsted A, Kamstrup PR, Nordestgaard BG (2014) Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular risk. Atherosclerosis 234(1):95\u2013101","journal-title":"Atherosclerosis"},{"key":"2597_CR21","first-page":"1","volume":"00","author":"BM Henry","year":"2020","unstructured":"Henry BM, Benoit SW, de Oliveira MHS, Lippi G, Favaloro EJ, Benoit JL (2020) ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol 00:1\u20138","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"2597_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/kisup.2012.1","volume":"2","author":"KDIGO AKI Working Group","year":"2012","unstructured":"KDIGO AKI Working Group (2012) KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2(1):1","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"2597_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2020050615","volume":"32","author":"L Chan","year":"2021","unstructured":"Chan L, Chaudhary K, Saha A, Chauhan K, Vaid A, Zhao S et al (2021) AKI in hospitalized patients with COVID-19. J Am Soc Nephrol 32(1):151\u2013160","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2597_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1681\/ASN.2020060897","volume":"32","author":"S Gupta","year":"2021","unstructured":"Gupta S, Coca SG, Chan L, Melamed ML, Brenner SK, Hayek SS et al (2021) AKI treated with renal replacement therapy in critically Ill patients with COVID-19. J Am Soc Nephrol 32(1):161\u2013176","journal-title":"J Am Soc Nephrol"},{"issue":"15","key":"2597_CR25","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1001\/jama.2020.17052","volume":"324","author":"M Kox","year":"2020","unstructured":"Kox M, Waalders NJB, Kooistra EJ, Gerretsen J, Pickkers P (2020) Cytokine levels in critically Ill patients with COVID-19 and other conditions. JAMA 324(15):1565","journal-title":"JAMA"},{"issue":"6","key":"2597_CR26","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/10408363.2016.1188055","volume":"53","author":"K Kotani","year":"2016","unstructured":"Kotani K, Serban M-C, Penson P, Lippi G, Banach M (2016) Evidence-based assessment of lipoprotein(a) as a risk biomarker for cardiovascular diseases\u2014some answers and still many questions. Crit Rev Clin Lab Sci 53(6):370\u2013378","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"2","key":"2597_CR27","doi-asserted-by":"publisher","first-page":"e0149427","DOI":"10.1371\/journal.pone.0149427","volume":"11","author":"E Sticchi","year":"2016","unstructured":"Sticchi E, Magi A, Kamstrup PR, Marcucci R, Prisco D, Martinelli I et al (2016) Apolipoprotein(a) Kringle-IV Type 2 copy number variation is associated with venous thromboembolism. PLoS ONE 11(2):e0149427","journal-title":"PLoS ONE"},{"issue":"5","key":"2597_CR28","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/01.CIR.0000048125.79640.77","volume":"107","author":"SR Holmer","year":"2003","unstructured":"Holmer SR, Hengstenberg C, Kraft H-G, Mayer B, P\u00f6ll M, K\u00fcrzinger S et al (2003) Association of polymorphisms of the Apolipoprotein(a) gene with Lipoprotein(a) levels and myocardial infarction. Circulation 107(5):696\u2013701","journal-title":"Circulation"},{"issue":"12","key":"2597_CR29","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1194\/jlr.M060210","volume":"56","author":"CA Scipione","year":"2015","unstructured":"Scipione CA, Sayegh SE, Romagnuolo R, Tsimikas S, Marcovina SM, Boffa MB et al (2015) Mechanistic insights into Lp(a)-induced IL-8 expression: a role for oxidized phospholipid modification of apo(a). J Lipid Res 56(12):2273\u20132285","journal-title":"J Lipid Res"},{"issue":"1","key":"2597_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1046\/j.1365-2141.2002.03245.x","volume":"116","author":"BE van Aken","year":"2002","unstructured":"van Aken BE, Reitsma PH, Rosendaal FR (2002) Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 116(1):173\u2013177","journal-title":"Br J Haematol"},{"issue":"5663","key":"2597_CR31","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS et al (2004) Neutrophil extracellular traps kill bacteria. Science 303(5663):1532\u20131535","journal-title":"Science"},{"issue":"8","key":"2597_CR32","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1161\/ATVBAHA.111.242859","volume":"32","author":"TA Fuchs","year":"2012","unstructured":"Fuchs TA, Brill A, Wagner DD (2012) NET impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 32(8):1777\u20131783","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"2597_CR33","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","volume":"33","author":"JI Borissoff","year":"2013","unstructured":"Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS et al (2013) Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 33(8):2032\u20132040","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"2597_CR34","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1182\/blood-2012-02-412197","volume":"120","author":"TA Fuchs","year":"2012","unstructured":"Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, L\u00e4mmle B (2012) Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 120(6):1157\u20131164","journal-title":"Blood"},{"issue":"1","key":"2597_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1471-2369-14-53","volume":"14","author":"Y Wu","year":"2013","unstructured":"Wu Y, Chen X, Yang Y, Wang B, Liu X, Tao Y et al (2013) A case of lipoprotein glomerulopathy with thrombotic microangiopathy due to malignant hypertension. BMC Nephrol 14(1):53","journal-title":"BMC Nephrol"},{"issue":"S1","key":"2597_CR36","doi-asserted-by":"publisher","first-page":"71A","DOI":"10.1016\/S0895-7061(03)00255-3","volume":"16","author":"JF Martin-Lazaro","year":"2003","unstructured":"Martin-Lazaro JF, Fabregate R, Bajo-Martinez A, Bernal E, Ugalde A, Calbacho M et al (2003) Selective elevation of von willebrand factor in patients with high lipoprotein (a) levels: an unknown prothrombotic risk factor in patients with hypertension and other risk factors. Am J Hypertens 16(S1):71A-71A","journal-title":"Am J Hypertens"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-021-02597-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-021-02597-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T08:14:58Z","timestamp":1649405698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-021-02597-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2597"],"URL":"https:\/\/doi.org\/10.1007\/s11239-021-02597-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,28]]},"assertion":[{"value":"21 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board (IRB) of the University of Cincinnati. This study was performed in line with the principles of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"This study received a waiver of informed consent due to no greater than minimal risk to participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}